Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Bergdolt

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Fortschritte Der Medizin|November 15, 1979
[The "Wiesloch model". Sports therapy and intervening prevention]H Bergdolt
Zeitschrift Fur Gastroenterologie|May 1, 1991
[Ranitidine in the therapy and prevention of NSAR-induced (non-steroidal anti-rheumatic agents) gastroduodenal lesions in patients with rheumatism]B Simon, H Bergdolt, H Dammann, et al.
Zeitschrift Fur Gastroenterologie|November 1, 1991
[75 mg roxatidine nocte protects human gastric mucosa against 300 mg acetylsalicylic acid nocte]B Simon, H Bergdolt, H G Dammann, et al.
Arzneimittel-Forschung|February 1, 1992
[Clinical studies on acid inhibition by ranitidine given simultaneously with pentagastrin]B Simon, H Bergdolt, H G Dammann, et al.
Arzneimittel-Forschung|August 1, 1991
[The effect of glycine on the gastroduodenal tolerability of acetylsalicylic acid. An endoscopic, controlled double-blind study in healthy subjects]P Müller, H G Dammann, H Bergdolt, et al.
Arzneimittel-Forschung|June 1, 1991
[Protection from gastroduodenal adverse effects of acetylsalicylic acid with ranitidine. An endoscopic controlled double-blind study of healthy subjects]P Müller, H G Dammann, H Bergdolt, et al.
Zeitschrift Fur Arztliche Fortbildung|June 1, 1996
[CINDI (Countrywide Integrated Noncommunicable Diseases Intervention) in Germany. A model for life style oriented, medical primary care for the population]W Fürniss, H Bergdolt, A Wiesemann, et al.
Sozial- Und Praventivmedizin|January 1, 1988
[Modification of the risk profile of obese essential hypertensive patients by the group "hypertension discussion" program]H D Basler, H Baumann, H H Beckers, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Fortschritte Der Medizin|November 15, 1979
[The "Wiesloch model". Sports therapy and intervening prevention]H Bergdolt
Zeitschrift Fur Gastroenterologie|May 1, 1991
[Ranitidine in the therapy and prevention of NSAR-induced (non-steroidal anti-rheumatic agents) gastroduodenal lesions in patients with rheumatism]B Simon, H Bergdolt, H Dammann, et al.
Zeitschrift Fur Gastroenterologie|November 1, 1991
[75 mg roxatidine nocte protects human gastric mucosa against 300 mg acetylsalicylic acid nocte]B Simon, H Bergdolt, H G Dammann, et al.
Arzneimittel-Forschung|February 1, 1992
[Clinical studies on acid inhibition by ranitidine given simultaneously with pentagastrin]B Simon, H Bergdolt, H G Dammann, et al.
Arzneimittel-Forschung|August 1, 1991
[The effect of glycine on the gastroduodenal tolerability of acetylsalicylic acid. An endoscopic, controlled double-blind study in healthy subjects]P Müller, H G Dammann, H Bergdolt, et al.
Arzneimittel-Forschung|June 1, 1991
[Protection from gastroduodenal adverse effects of acetylsalicylic acid with ranitidine. An endoscopic controlled double-blind study of healthy subjects]P Müller, H G Dammann, H Bergdolt, et al.
Zeitschrift Fur Arztliche Fortbildung|June 1, 1996
[CINDI (Countrywide Integrated Noncommunicable Diseases Intervention) in Germany. A model for life style oriented, medical primary care for the population]W Fürniss, H Bergdolt, A Wiesemann, et al.
Sozial- Und Praventivmedizin|January 1, 1988
[Modification of the risk profile of obese essential hypertensive patients by the group "hypertension discussion" program]H D Basler, H Baumann, H H Beckers, et al.
Pageof 1